Pharmaceuticals

Health By Erin Brodwin

First-of-its-kind study pits psilocybin against a common antidepressant

Pharmalot By Ed Silverman

FDA is urged to move faster to list medicines withdrawn over safety concerns

Politics By Nicholas Florko

PhRMA chief talks strategy — and he’s surprisingly optimistic about drug pricing reform

Opinions+ By Sam Volchenboum

Building the perfect wearable for clinical trials

First Opinion By Andrei Iancu

No evidence that patents slow access to vaccines

Pharma By Jessica Davis Plüss

Europe tries to lower drug prices with small doses of transparency

Pharmalot By Ed Silverman

Federal agency says pharma should pay higher Medicaid rebates if certain trials aren’t finished on time

Opinions+ By Pierre Bourdage

Three steps toward creating a functioning U.S. biosimilars market

Pharmalot By Ed Silverman

A controversial court case in Brazil will tackle pharma ‘monopolies’ and access to drugs

Pharmalot By Ed Silverman

Lilly is a holdout among companies that agree to disclose when executive pay is clawed back

First Opinion By David Hyun and Rachel Zetts

Many hospitalized Covid-19 patients are given antibiotics. That’s a problem

Pharmalot By Ed Silverman

Former top Lilly lobbyist sues the company for alleged sex discrimination and harassment

First Opinion By Marvin D. Seppala

Money from opioid lawsuits is urgently needed now

Pharmalot By Ed Silverman

EPA rule that could help citrus growers is challenged over concerns about antibiotic resistance

Health Tech By Erin Brodwin

With Amazon and Ro on its heels, Uber expands its prescription delivery business

Opinions+ By Krishanu Saha

A Biden-Harris Biomanufacturing Initiative could increase supplies of vaccines, therapeutics in one fell swoop

Pharmalot By Ed Silverman

Pharma mergers face fresh scrutiny by a new international antitrust group

Pharmalot By Ed Silverman

Ohio attorney general sues a health plan over its PBM contracts and Medicaid costs

Pharmalot By Ed Silverman

Pharmalittle: Biden urged by former FDA commissioners to pick agency chief; Lilly reports more positive data for Covid-19 drug

Pharmalot By Ed Silverman

Pharmalittle: Covid-19 forces FDA to postpone inspections; pharma urges Biden to reject WTO proposal

Pharmalot By Ed Silverman

Pharmalittle: Merck says early data shows pill is effective against Covid-19; WHO’s COVAX program ships first doses

Opinions+ By Saul Helman and David Weiss

Making pharma’s post-Covid-19 future faster and smarter

Pharmalot By Ed Silverman

Physician and patients may prefer brand-name drugs, but they cost Medicare Part D a lot of money

First Opinion By Michelle McMurry-Heath

The Biden administration’s pandemic agenda must not ignore superbugs

The cost of healthcare health technology assessment

Opinions+ By Darius Lakdawalla, Peter Neumann, and Gail Wilensky

Most Read

Merck reaches deal with Austrian antitrust regulators over ‘predatory’ pricing for a cancer drug

Digital pharmacy startup Thirty Madison taps former Lilly exec as president

Drug used to halt puberty in children may cause lasting health problems

Cavazzoni to take over influential spot atop FDA drug center

I have spinal muscular atrophy. Critics of the $2 million new gene therapy are missing the point

Failure to warn: Hundreds died while taking an arthritis drug, but nobody alerted patients

José Baselga, renowned cancer researcher and AstraZeneca oncology R&D head, dies at 61

Unprecedented development of Covid-19 vaccines, treatments points to biopharma’s future

All Coverage

First-of-its-kind study pits psilocybin against a common antidepressant

FDA is urged to move faster to list medicines withdrawn over safety concerns

PhRMA chief talks strategy — and he’s surprisingly optimistic about drug pricing reform

Building the perfect wearable for clinical trials

No evidence that patents slow access to vaccines

Europe tries to lower drug prices with small doses of transparency

Federal agency says pharma should pay higher Medicaid rebates if certain trials aren’t finished on time

Three steps toward creating a functioning U.S. biosimilars market

A controversial court case in Brazil will tackle pharma ‘monopolies’ and access to drugs

Lilly is a holdout among companies that agree to disclose when executive pay is clawed back

Many hospitalized Covid-19 patients are given antibiotics. That’s a problem

Former top Lilly lobbyist sues the company for alleged sex discrimination and harassment

Money from opioid lawsuits is urgently needed now

EPA rule that could help citrus growers is challenged over concerns about antibiotic resistance

With Amazon and Ro on its heels, Uber expands its prescription delivery business

A Biden-Harris Biomanufacturing Initiative could increase supplies of vaccines, therapeutics in one fell swoop

Pharma mergers face fresh scrutiny by a new international antitrust group

Ohio attorney general sues a health plan over its PBM contracts and Medicaid costs

Pharmalittle: Biden urged by former FDA commissioners to pick agency chief; Lilly reports more positive data for Covid-19 drug

Pharmalittle: Covid-19 forces FDA to postpone inspections; pharma urges Biden to reject WTO proposal

Pharmalittle: Merck says early data shows pill is effective against Covid-19; WHO’s COVAX program ships first doses

Making pharma’s post-Covid-19 future faster and smarter

Physician and patients may prefer brand-name drugs, but they cost Medicare Part D a lot of money

The Biden administration’s pandemic agenda must not ignore superbugs

Create a U.S. Institute of Health Technology Assessment to preserve innovation and control costs

pharmaceuticals

Most Read

All Coverage